Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;23(13):1054-1066.
doi: 10.2174/1389200224666221209154002.

Influence of Zhuanggu Guanjie Pill on Seven Cytochrome P450 Enzymes Based on Probe Cocktail and Pharmacokinetics Approaches

Yuan-Yuan Chai  1 , Yun-Xia Xu  1 , Zi-Yin Xia  1 , An-Qin Li  1 , Xin Huang  1   2 , Lu-Yong Zhang  1   3 , Zhen-Zhou Jiang  1   4
Affiliations

Influence of Zhuanggu Guanjie Pill on Seven Cytochrome P450 Enzymes Based on Probe Cocktail and Pharmacokinetics Approaches

Yuan-Yuan Chai et al. Curr Drug Metab. 2022.

Abstract

Background: The use of herbal medicines has tremendously increased over the past few decades. Case reports and controlled clinical investigations of herbal-drug interactions have been reported. Since Cytochrome P450 (CYP) enzymes play an important role in drug interactions. The evaluation of the influence of herbal medicines on the activities of CYPs is beneficial to promote scientific and rational clinical use of herbal medicines.

Objective: Herein, we aimed to develop and validate a method to simultaneously quantify seven CYP cocktail probe drugs consisting of phenacetin (PNC), bupropion (BPP), losartan potassium (LK), omeprazole (OMP), dextromethorphan (DM), chlorzoxazone (CZZ) and midazolam (MDZ) and their respective metabolites in a single acquisition run and use this method to evaluate the influence of Zhuanggu Guanjie Pill (ZGGJP) on seven CYPs.

Methods: A cost-effective and simple UHPLC-(±)ESI-MS/MS method for simultaneous determination of seven probe drugs and metabolites in rat plasma was developed and validated. Male and female rats were randomly divided into three groups and treated with 1.2 g/kg/d ZGGJP, 5 g/kg/d ZGGJP and 0.5% CMC-Na for 14 consecutive days. After 24 h of the last administration, all rats were administrated orally with probe drugs. The influence of ZGGJP on the CYPs was carried out by comparing the metabolic ratio (Cmax, AUC0-t) of metabolites/probe drugs in rats.

Results: The calibration curves were linear, with correlation coefficient > 0.99 for seven probe drugs and their corresponding metabolites. Intra- and inter-day precisions were not greater than 15% RSD and the accuracies were within ± 15% of nominal concentrations. The ZGGJP showed significant inductive effect on CYP1A2, CYP2B6, CYP2C9 and CYP3A in male and female rats.

Conclusion: ZGGJP had inductive effects on CYP1A2, CYP2B6, CYP2C9 and CYP3A in male and female rats.

Keywords: Cytochrome P450; UHPLC-(±)ESI-MS/MS; Zhuanggu Guanjie Pill.; cocktail probe; post-column infusion; rat plasma.

PubMed Disclaimer

References

    1. Petsalo A.; Turpeinen M.; Pelkonen O.; Tolonen A.; Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography–tandem mass spectrometry utilizing sub 2μm particle size column. J Chromatogr A 2008,1215(1-2),107-115 - DOI - PubMed
    1. Lee J.T.; Pao L.H.; Hsiong C.H.; Huang P.W.; Shih T.Y.; Yoa-Pu Hu O.; Validated liquid chromatography–tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases. Talanta 2013,106,220-228 - DOI - PubMed
    1. Varshney E.; Tandon M.; Saha N.; Ali S.; In vivo phenotyping of cytochrome 450 isoforms involved in the metabolism of anti-HIV and anti-tubercular drugs in human using cocktail approach: An LC–MS/MS analysis. J Pharm Biomed Anal 2019,164,698-705 - DOI - PubMed
    1. Cusinato D.A.C.; Filgueira G.C.O.; Rocha A.; Cintra M.A.C.T.; Lanchote V.L.; Coelho E.B.; LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses. J Pharm Biomed Anal 2019,164,430-441 - DOI - PubMed
    1. Williams D.; Tao X.; Zhu L.; Stonier M.; Lutz J.D.; Masson E.; Zhang S.; Ganguly B.; Tzogas Z.; Lubin S.; Murthy B.; Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator. Br J Clin Pharmacol 2017,83(2),370-380 - DOI - PubMed

LinkOut - more resources